Ultrasensitive Quantification of MUC16 Antigen/Amine-terminated Aptamer Interaction by Surface Plasmon Resonance: Kinetic and Thermodynamic Studies

IF 3.1 Q2 PHARMACOLOGY & PHARMACY Advanced pharmaceutical bulletin Pub Date : 2024-01-13 DOI:10.34172/apb.2024.028
Shahnam Valizadeh Shahbazlou, S. Vandghanooni, Bahareh Dabirmanesh, M. Eskandani, S. Hasannia
{"title":"Ultrasensitive Quantification of MUC16 Antigen/Amine-terminated Aptamer Interaction by Surface Plasmon Resonance: Kinetic and Thermodynamic Studies","authors":"Shahnam Valizadeh Shahbazlou, S. Vandghanooni, Bahareh Dabirmanesh, M. Eskandani, S. Hasannia","doi":"10.34172/apb.2024.028","DOIUrl":null,"url":null,"abstract":"MUC16 is a commonly employed biomarker in the identification and prognosis of ovarian cancer (OC). Precise measurement of MUC16 levels is essential for the accurate diagnosis, prediction, and management of OC. This research seeks to introduce a new surface plasmon resonance (SPR) biosensor design that utilizes aptamer-based technology to enable the sensitive and real-time detection of MUC16. In this study, the sensor chip was immobilized with an anti-MUC16 aptamer (Ap) by utilizing 11-mercaptoundecanoic acid (MUA) as a linker to attach the amine-terminated Ap to the chip using EDC/NHS chemistry. The results indicated that the newly created aptasensor had a detection limit of 0.03 U mL-1 for MUC16 concentration, with a linear range of 0.09 to 0.027 U mL-1. The findings demonstrate good precision and accuracy (<15%) for each MUC16 concentration, with recoveries ranging from 93% to 96%. Additionally, the aptasensor exhibited high selectivity, good repeatability, stability, and applicability in real human serum samples, indicating its potential as a valuable tool for the diagnosis and treatment of ovarian cancer.","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced pharmaceutical bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/apb.2024.028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

MUC16 is a commonly employed biomarker in the identification and prognosis of ovarian cancer (OC). Precise measurement of MUC16 levels is essential for the accurate diagnosis, prediction, and management of OC. This research seeks to introduce a new surface plasmon resonance (SPR) biosensor design that utilizes aptamer-based technology to enable the sensitive and real-time detection of MUC16. In this study, the sensor chip was immobilized with an anti-MUC16 aptamer (Ap) by utilizing 11-mercaptoundecanoic acid (MUA) as a linker to attach the amine-terminated Ap to the chip using EDC/NHS chemistry. The results indicated that the newly created aptasensor had a detection limit of 0.03 U mL-1 for MUC16 concentration, with a linear range of 0.09 to 0.027 U mL-1. The findings demonstrate good precision and accuracy (<15%) for each MUC16 concentration, with recoveries ranging from 93% to 96%. Additionally, the aptasensor exhibited high selectivity, good repeatability, stability, and applicability in real human serum samples, indicating its potential as a valuable tool for the diagnosis and treatment of ovarian cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过表面等离子体共振对 MUC16 抗原/氨端肽相互作用进行超灵敏定量:动力学和热力学研究
MUC16是卵巢癌(OC)鉴别和预后常用的生物标志物。精确测量 MUC16 水平对于准确诊断、预测和管理卵巢癌至关重要。本研究试图引入一种新的表面等离子体共振(SPR)生物传感器设计,利用基于适配体的技术实现对 MUC16 的灵敏和实时检测。在这项研究中,利用 11-巯基十酸酐(MUA)作为连接剂,通过 EDC/NHS 化学方法将氨基末端的 Ap 连接到芯片上,从而用抗 MUC16 的适配体(Ap)固定传感器芯片。结果表明,新创建的灵敏传感器对 MUC16 浓度的检测限为 0.03 U mL-1,线性范围为 0.09 至 0.027 U mL-1。研究结果表明,每种浓度的 MUC16 都具有良好的精密度和准确度(<15%),回收率在 93% 至 96% 之间。此外,该灵敏传感器在真实人体血清样本中表现出高选择性、良好的可重复性、稳定性和适用性,表明它有望成为诊断和治疗卵巢癌的重要工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advanced pharmaceutical bulletin
Advanced pharmaceutical bulletin PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
2.80%
发文量
51
审稿时长
12 weeks
期刊最新文献
Exploring the Interplay between the Warburg Effect and Glucolipotoxicity in Cancer Development: A Novel Perspective on Cancer Etiology. Cytobiological Alterations Induced by Celecoxib as an Anticancer Agent for Breast and Metastatic Breast Cancer. Development of Gentamicin Bilosomes Laden In Situ Gel for Topical Ocular Delivery: Optimization, In Vitro Characterization, Toxicity, and Anti-microbial Evaluation. Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells. Evaluating the Accuracy of Large Language Model (ChatGPT) in Providing Information on Metastatic Breast Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1